- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Grafoid Signs with Altamat, Expanding into Graphene-3D Printing Materials Sector
Grafoid Inc. announced it signed an agreement with Altamat Inc. for the construction of an atomization facility to produce MesoGraf™graphene-based powders and filaments for 3D printing. Altamat Inc. is an advanced materials manufacturing consultancy founded by Dr. Henein, an expert in materials process engineering for metals, metallic alloys and composites.
As quoted in the press release:
The agreement provides Grafoid with the exclusive global rights to apply technologies invented by Dr. Henein for use in a wide range of functionalized powders for 3D printing applications.
Grafoid believes MesoGraf™ sets the global standard for high-energy density graphene from a globally patented process. That process uniquely transforms raw, unprocessed graphite ore to affordable and scalable, high-purity, few layer graphene.
Graphoid CEO, Gary Economo, said:
Success in 3D graphene printed materials markets comes from an ability to create the highest performing products at the lowest possible cost on a safe and environmentally sustainable basis.
Our agreement with Altamat and Dr. Henein’s engineering expertise adds yet another element to Grafoid’s expanding portfolio of MesoGraf™ graphene development.
Click here to read the Grafoid Inc. press release
Click here to see the Grafoid Inc. profile.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â